N-acetylgalactosamine-6-sulfate sulfatase in human placenta: purification and characteristics

J Biochem. 1991 Dec;110(6):965-70. doi: 10.1093/oxfordjournals.jbchem.a123697.

Abstract

N-Acetylgalactosamine-6-sulfate sulfatase from human placenta was purified 33,600-fold using beta-N-acetyl-D-galactosamine 6-sulfate-(1----4)-beta-D-glucuronic acid-(1----3)-N-acetyl-D-[3H]galactosaminitol 6-sulfate as the substrate. This enzyme is an oligomer with a molecular mass of 120 kDa and consists of polypeptides of 40 and 15 kDa. The 15 kDa polypeptide is a glycoprotein. This purified protein has activities of N-acetylgalactosamine-6-sulfate sulfatase and galactose-6-sulfate sulfatase. Rabbit antiserum was raised against the purified protein. The antibody titrated N-acetylgalactosamine-6-sulfate sulfatase and galactose-6-sulfate sulfatase. The size of the precursor of the enzyme is 60 kDa, as determined by cell-free translation. The optimal pH values of the N-acetylgalactosamine-6-sulfate sulfatase and galactose-6-sulfate sulfatase activities are pH 3.8-4.0, and the Kms are 8 and 13 microM, respectively. Sulfate and phosphate ions are potent competitive inhibitors for the enzyme and their inhibition constants are 35 and 200 microM, respectively. Cross-reactive materials of 40 and 15 kDa were detected by immunoblot analysis, in the placenta, liver, and normal fibroblasts, but not in fibroblasts from a patient with Morquio disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chondroitinsulfatases / chemistry
  • Chondroitinsulfatases / isolation & purification*
  • Chondroitinsulfatases / metabolism
  • Female
  • Humans
  • Hydrogen-Ion Concentration
  • Kinetics
  • Molecular Weight
  • Placenta / enzymology*
  • Pregnancy
  • Protein Conformation
  • Substrate Specificity

Substances

  • Chondroitinsulfatases